Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia:an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation)

References

• Reddy NK, Kumar DN, Rayudu NV, et al. Prevalence of risk factors for coronary atherosclerosis in a cross-sectional population of Andhra Pradesh. Indian Heart J 2002;54: 697–701
   PubMedGoogle Scholar
• Misra A. Atherosclerosis in Indians and lipoprotein (a). J Assoc Physicians India 1999;47:313–7
   PubMedGoogle Scholar
• Puri A, Gupta OK, Dwivedi RN, et al. Homocysteine and lipid levels in young patients with coronary artery disease. J Assoc Physicians India 2003;51:681–5
   PubMedGoogle Scholar
• Goel PK, Bharti BB, Pandey CM, et al. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Indian Heart J 2003;55:234–40
   PubMedGoogle Scholar
• Balaranmjan R. Ethnicity and variations in mortality from coronary heart disease. Health Trends 1996;28:45–51
   Google Scholar
• McKeigue PM, Shah B, Mermott MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382–8
   Google Scholar
• Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279–84
   PubMed Web of Science ®Google Scholar
• Butz LW, du Vigneaud V. The formation of a homologue of cystine by the decomposition of methionine with sulfuric acid. J Biol Chem 1932;99:135–42
   Google Scholar
• Green R, Jacobsen DW. Clinical implications of hyperhomocysteinemia. In: Bailey LB, editor. Folate in health and disease. New York: Marcel Dekker; 1995. p. 75–122
   Google Scholar
• Malinow MR, Bostom AG, Krauss RM. Homocysteine, diet, and cardiovascular diseases: a statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 1999;99:178–82
   Google Scholar
• Prasad K. Homocysteine, a risk factor for cardiovascular disease. Int J Angiology 1999;8:76–86
   PubMedGoogle Scholar
• Boushey CJ, Beresford SA, Omen GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049–57
   PubMed Web of Science ®Google Scholar
• Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic heart disease: results of a prospective study with implications on prevention. Arch Internal Med 1998;158:862–7
   PubMed Web of Science ®Google Scholar
• McCully KS. Homocysteine and vascular disease. Nat Med 1996;2:386–9
   PubMed Web of Science ®Google Scholar
• Graham IM, Daly LE, Refsum H, et al. Plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 1997;277:1775–81
   PubMed Web of Science ®Google Scholar
• Ueland PM, Refsum H. Plasma homocysteine – a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J Lab Clin Med 1989;114:473–501
   PubMed Web of Science ®Google Scholar
• Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart diseases in UK Indian Asian and European men. Lancet 2000;355:523–7
   PubMed Web of Science ®Google Scholar
• Refsum H, Yajnik CS, Gadkari M, et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001;74:233–41
   PubMed Web of Science ®Google Scholar
• Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL. Folic acid – an innocuous means to reduce plasma homocysteine. Scan J Clin Lab Invest 1988;48:215–21
   PubMed Web of Science ®Google Scholar
• Saltzman E, Mason JB, Jacques PF, et al. B vitamin supplementation lowers homocysteine levels in heart disease [abstract]. Clin Res 1994;42:172A
   Google Scholar
• Schnyder G, Roffi M, Flammer Y, et al. Effect of homocysteine-lowering therapy with folic acid, Vitamin B12 and Vitamin B6 on clinical outcome after percutaneous coronary intervention. J Am Med Assoc 2002;288:973–9
   PubMed Web of Science ®Google Scholar
• Brouwer IA, van Dusseldorp M, Thomas CMG, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentration: a randomized trial. Am J Clin Nutr 1999;69: 99–104
   PubMed Web of Science ®Google Scholar
• Lobo A, Naso A, Arheart K, et al. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12. Am J Cardiol 1999;83:821–5
   PubMed Web of Science ®Google Scholar
• Nallamothu BK, et al. Homocysteine and coronary heart disease. Pharmacoeconomics 2002;20:429–42
   PubMedGoogle Scholar
• Bostom AG, Selhub J. Homocysteine and arteriosclerosis: subclinical and clinical disease associations. Circulation 1999;99:2361–3
   PubMed Web of Science ®Google Scholar
• Bostom AG, Garber C. Endpoints for homocysteine – lowering trials. Lancet 2000;355:511–2
   PubMed Web of Science ®Google Scholar
• THcy Lowering Trialists’ Collaboration. Lowering blood homo-cysteine with folic acid based supplements: meta-analysis of randomized trials. Br Med J 1998;316:894–8
   PubMedGoogle Scholar
• Hazra A, Tripathi SK. Folic acid revisited. Indian J Pharmacol 2001;33:322–42
   Google Scholar
• Questionnaire based assessment – physical inactivity in WHO STEPwise approach to NCD surveillance – final draft, World Health Organisation; 2001
   Google Scholar
• Emsley AM, Plane F, Jackson CL, et al. Oxidant stress, nitric oxide, and transition metals in homocysteinemic angiopathy: novel mechanisms. Vascular Disease 1998;1:66–72
   Google Scholar
• Riddell LJ, Chisholm A, Williams S, Mann JI. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr 2000;71:1448–54
   PubMed Web of Science ®Google Scholar
• Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. New Engl J Med 1999;340:1449–54
   PubMed Web of Science ®Google Scholar
• Misra A, Vikram N, Dwivedi M, et al. High homocysteine levels in healthy people belonging to upper-middle and lower socio-economic strata in New Delhi [All India Institute of Medical Sciences, New Delhi] J Assoc Physicians India 2002;50:211[abstract]
   Google Scholar
• Puri A, Gupta O, Dwivedi R, et al. Homocysteine in patients under 45 years of age with coronary insufficiency, PGIM, Kanpur. J Assoc Physicians India 2002;50:63[abstract]
   Google Scholar
• Robinson K. Homocysteine and coronary artery disease. In: Carmel R, Jacobson DW, editors. Homocysteine in health and disease. Cambridge: Cambridge University press; 2001
   Google Scholar
• Bonna KH; on behalf of the NORVIT study group. Randomised trial of homocysteine-lowering with B vitamins for secondary prevention of cardiovascular disease after acute myocardial infarction. The Norwegian Vitamin Study (NORVIT). Available from: http://www.escardio.org [last accessed on 20 Jan 2006]
   Google Scholar
• Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;354:407–13
   PubMed Web of Science ®Google Scholar